Sangani Hospitals Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Sangani Hospitals Ltd is ₹ 59.7 as of 23 Oct 15:30 . The P/E Ratio of Sangani Hospitals Ltd changed from 21.7 on March 2024 to 17.9 on March 2026 . This represents a CAGR of -6.22% over 3 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Sangani Hospitals Ltd changed from ₹ 58.55 crore on March 2024 to ₹ 53.59 crore on March 2026 . This represents a CAGR of -2.91% over 3 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The Dividend Payout of Sangani Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Sangani Hospitals Ltd

Sangani Hospitals Limited was incorporated as a Public Limited Company in Keshod, Gujarat on November 11, 2021, through Certificate of Incorporation dated November 12, 2021 and Certificate of Commencement of Business dated December 14, 2021 issued by the Registrar of Companies, Ahmedabad.
Sangani Group is a healthcare organization founded by the Promoter, Dr. Ajaykumar Sangani. Sangani Hospital is 36 beds multi-speciality hospital with primary, secondary and tertiary care facilities.
Presently, the Company is into the business of Hospitals, pathological laboratory and Pharmacy stores at Keshod and Veraval location in Gujarat.
The Company is a multi-speciality healthcare provider operating in Keshod and Veraval region of Gujarat with a combined bed capacity of 170 beds.
Their services include super speciality services, speciality services and other support services.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Sangani Hospitals Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Sangani Hospitals Ltd or Vanta Bioscience Ltd?

Market cap of Sangani Hospitals Ltd is 82 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Sangani Hospitals Ltd and Vanta Bioscience Ltd?

The stock performance of Sangani Hospitals Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sangani Hospitals Ltd and Vanta Bioscience Ltd?

As of October 24, 2026, the Sangani Hospitals Ltd stock price is INR ₹59.7. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Sangani Hospitals Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Sangani Hospitals Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.